Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust

Leuk Lymphoma. 2022 Jan;63(1):227-230. doi: 10.1080/10428194.2021.1973671. Epub 2021 Sep 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Hematologic Neoplasms*
  • Humans
  • London
  • SARS-CoV-2
  • State Medicine